Physician Profile
Based in Lansing, MI, Mhd Iyad Alshwaf, MD is listed in the NPI registry under rheumatology. Medicare claims data shows Mhd Iyad provided 56,315 services to 1,702 patients. The services billed most often include injection, golimumab, 1 mg, for intravenous use, injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered), and injection, romosozumab-aqqg, 1 mg. NPI 1801399365 identifies this record in the national registry.
Factual summary compiled by Guide.md from public records; not written by this provider.
Exactly as CMS reports it (National Downloadable File, Opt-Out Affidavits, Order & Referring). Not an insurance directory; confirm coverage with the office.
4052 LEGACY PKWY SUITE 200
Lansing, MI 48911
Within Rheumatology generally. Availability varies by clinician, training and location — this profile has not been claimed, so nothing here is a personal claim by the provider.
Most searched conditions
Autoimmune
Bone
Bone Health
Connective Tissue
Genetic & Connective Tissue
Inflammatory
Joints
Nerve & Tendon
Skin & Soft Tissue
Skin & Vascular
Soft Tissue
Spine & Back
Vascular
Most searched procedures
Consultation
Consultations
Diagnostics & Injections
Education & Support
Imaging
Injections
Lab & Diagnostics
Lab Work
Medication Management
Pain Relief
Regenerative Medicine
56,315 services · 1,702 patients · 25 distinct codes
| Procedure | Type | Code | Services | Compared with peers |
|---|---|---|---|---|
| Insertion of needle into vein for collection of blood sample | Procedure | 36415 |
100 | Less often than most peers in Rheumatology |
| Aspiration and/or injection of fluid from large joint | Procedure | 20610 |
29 | As often as other peers in Rheumatology |
| Ultrasonic guidance for needle placement | Imaging | 76942 |
16 | Less often than most peers in Rheumatology |
| Injection of drug or substance under skin or into muscle | Treatment | 96372 |
349 | More often than most peers in Rheumatology |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Treatment | 96365 |
289 | More often than most peers in Rheumatology |
| Injection of additional new drug or substance into vein | Treatment | 96375 |
149 | More often than most peers in Rheumatology |
| Administration of chemotherapy into vein, each additional hour | Treatment | 96415 |
139 | As often as other peers in Rheumatology |
| Administration of chemotherapy into vein, 1 hour or less | Treatment | 96413 |
114 | As often as other peers in Rheumatology |
| Influenza vaccine, inactivated | Treatment | 90653 |
20 | As often as other peers in Rheumatology |
| Injection, golimumab, 1 mg, for intravenous use | Drug given | J1602 |
16,900 | As often as other peers in Rheumatology |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Dr. Alshwaf is a rheumatologist in Lansing, MI. That is the designation recorded for this NPI in the federal registry, where it is listed as “Rheumatology”.
NPI registry
Dr. Alshwaf is listed at 4052 Legacy Pkwy Suite 200, Lansing, MI 48911. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
The number on file is (517) 272-9700. Contact the office directly to confirm availability and scheduling.
NPI registry
Dr. Alshwaf's National Provider Identifier is 1801399365. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Dr. Alshwaf attended Other, graduating in 1991. This comes from the CMS National Downloadable File.
CMS public data
Dr. Alshwaf has 35 years experience. Calculated from a graduation year of 1991, reported in the CMS National Downloadable File.
CMS public data
According to Medicare billing data, Dr. Alshwaf performs procedures including insertion of needle into vein for collection of blood sample and aspiration and/or injection of fluid from large joint; reads or performs imaging such as ultrasonic guidance for needle placement; provides treatments such as injection of drug or substance under skin or into muscle and infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Not yet. This profile is built from public federal data and has not been confirmed by Dr. Alshwaf. If this is you, claiming it is free.
Guide.md
Guide.md listings do not constitute medical advice or an endorsement.